Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6G9D

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-X
Temperature [K]100
Detector technologyPIXEL
Collection date2015-01-14
DetectorDECTRIS PILATUS 300K
Wavelength(s)1.54178
Spacegroup nameP 1 21 1
Unit cell lengths48.836, 70.510, 60.357
Unit cell angles90.00, 109.43, 90.00
Refinement procedure
Resolution46.060 - 1.800
R-factor0.169
Rwork0.166
R-free0.22300
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.013
RMSD bond angle1.100
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]46.0601.830
High resolution limit [Å]1.8001.800
Rmerge0.0380.607
Rmeas0.0380.607
Number of reflections351831244
<I/σ(I)>17.7
Completeness [%]99.479.2
Redundancy2.8
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22930.3M (NH4)2SO4, 32.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol

222624

PDB entries from 2024-07-17

PDB statisticsPDBj update infoContact PDBjnumon